Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Backing Materials in Transdermal Patches Production

Posted on By

SOP for Use of Backing Materials in Transdermal Patches Production

Standard Operating Procedure for Use of Backing Materials in Transdermal Patches Production

1) Purpose

The purpose of this SOP is to define procedures for the selection, handling, and application of backing materials used in the production of transdermal patches.

2) Scope

This SOP applies to the use of backing materials during all stages of transdermal patch production, including formulation, lamination, and final assembly, within the facility.

3) Responsibilities

The Production Department is responsible for implementing and overseeing the use of backing materials as per this SOP. Quality Control (QC) personnel may conduct checks and inspections as required.

See also  SOP for Annual Product Review in Transdermal Patches Production

4) Procedure

4.1 Backing Material Selection

  • 4.1.1 Select backing materials based on product specifications, including barrier properties, flexibility, and compatibility with patch components.
  • 4.1.2 Verify that selected materials meet regulatory requirements and are sourced from approved suppliers.

4.2 Handling and Storage

  • 4.2.1 Store backing materials in controlled conditions (e.g., temperature and humidity) to prevent moisture absorption, contamination, or damage.
  • 4.2.2 Handle materials with care to avoid tears, folds, or other physical damage that could affect their performance in patch production.

4.3 Application and Lamination

  • 4.3.1 Prepare backing materials for lamination by ensuring cleanliness and compatibility with adhesive and active ingredient layers.
  • 4.3.2 Apply backing materials according to validated procedures and
batch-specific instructions to achieve secure bonding and uniform coverage.

4.4 Quality Control Checks

  • 4.4.1 Perform visual inspections and dimensional checks on finished patches to ensure backing materials are properly aligned and free from defects.
  • 4.4.2 Conduct peel strength and barrier property tests (if applicable) to verify the integrity and performance of the backing materials.

4.5 Documentation and Reporting

  • 4.5.1 Document all activities related to the use of backing materials in batch records or production logs, including material details, application parameters, and quality control results.
  • 4.5.2 Record any deviations from standard procedures and document corrective actions taken to address issues promptly.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control

6) Documents, if any

Backing Material Specifications
Batch Records
Supplier Certificates

7) Reference, if any

USP General Chapter 1151: Pharmaceutical Dosage Forms
ISO 11607: Packaging for Terminally Sterilized Medical Devices

8) SOP Version

Version 1.0

See also  SOP for Adhesion Testing of Transdermal Patches
Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Lyophilization Cycle Development
Next Post: SOP for Distribution and Transport Conditions for Aerosols

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version